Advisor Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $31K | Buy |
9,451
+500
| +6% | +$1.64K | ﹤0.01% | 3713 |
|
|
2019
Q3 | $19K | Sell |
8,951
-1,500
| -14% | -$3.18K | ﹤0.01% | 3998 |
|
|
2019
Q2 | $34K | Buy |
10,451
+5,050
| +94% | +$16.4K | ﹤0.01% | 3634 |
|
|
2019
Q1 | $20K | Buy |
5,401
+2,968
| +122% | +$11K | ﹤0.01% | 3989 |
|
|
2018
Q4 | $7K | Sell |
2,433
-2,025
| -45% | -$5.83K | ﹤0.01% | 4397 |
|
|
2018
Q3 | $12K | Buy |
4,458
+300
| +7% | +$808 | ﹤0.01% | 4209 |
|
|
2018
Q2 | $10K | Buy |
4,158
+2,000
| +93% | +$4.81K | ﹤0.01% | 4096 |
|
|
2018
Q1 | $6K | Sell |
2,158
-2,251
| -51% | -$6.26K | ﹤0.01% | 4366 |
|
|
2017
Q4 | $13K | Sell |
4,409
-290
| -6% | -$855 | ﹤0.01% | 3963 |
|
|
2017
Q3 | $16K | Buy |
4,699
+1,540
| +49% | +$5.24K | ﹤0.01% | 3712 |
|
|
2017
Q2 | $7K | Sell |
3,159
-32
| -1% | -$71 | ﹤0.01% | 4134 |
|
|
2017
Q1 | $7K | Buy |
3,191
+251
| +9% | +$551 | ﹤0.01% | 4007 |
|
|
2016
Q4 | $7K | Sell |
2,940
-10
| -0.3% | -$24 | ﹤0.01% | 3810 |
|
|
2016
Q3 | $10K | Sell |
2,950
-102,116
| -97% | -$346K | ﹤0.01% | 3587 |
|
|
2016
Q2 | $328K | Buy |
+105,066
| New | +$328K | 0.01% | 1151 |
|